Premonitory Urges and the Feeling Before a Tic

Share this post:

LinkedIn
Facebook
X
Reddit
WhatsApp
Print

A premonitory urge is an uncomfortable body feeling that can happen right before a tic. You may feel pressure, tension, itching, tightness, tingling or a need to move or make a sound. The tic may bring brief relief, then the feeling may return. The National Institute of Neurological Disorders and Stroke (NINDS) says some tics are preceded by an urge or sensation in the affected muscle group, called a premonitory urge.

The body feeling before a tic

A premonitory urge can feel different from person to person. Some people feel it in the exact body area where the tic happens. A blinking tic may come after a burning or pressure feeling in the eyes. A neck tic may come after tightness in the neck. A throat clearing tic may come after a dry, scratchy or tense feeling in the throat.

The urge can feel like an itch, sneeze or pressure that needs release. The tic may reduce the feeling for a short time. After that, the urge may build again. Mayo Clinic describes premonitory urges as uncomfortable body sensations such as an itch, tingle or tension before a motor or vocal tic, with relief after the tic occurs.

You may be able to hold back the tic for a short period. That effort can feel tiring. Some people suppress tics at school, work or public events, then tic more when they get home. This does not make the tic fake. It means the person used effort to delay the response.

Premonitory urges can happen before motor tics and vocal tics. They may appear before blinking, shoulder movements, head jerks, sniffing, humming, throat clearing, words or phrases.

Why the urge can feel hard to explain

Premonitory urges are internal. Other people cannot see them. A parent, teacher, coworker or friend may only see the tic, not the discomfort before it. This can lead to wrong assumptions about control.

You may know the tic is coming before anyone else can see it. You may also feel the urge without having the words to describe it. Some people say it feels like pressure. Others say it feels like something is incomplete until the tic happens.

A premonitory urge can also be stronger than the tic itself. A 2025 scoping review in Frontiers in Psychiatry described premonitory urges as uncomfortable body sensations before tics that often build before the tic and ease after the tic is performed. The review also notes earlier findings where many participants described these urges as distressing.

The urge can make tics feel different from ordinary habits. A habit may be tied to routine or boredom. A tic often has a body urge, a sudden quality and brief relief after it happens.

Children who cannot describe the urge yet

Young children may have premonitory urges but struggle to explain them. A child may say “I have to do it,” “my eyes feel weird” or “my throat wants it.” Some children may only show distress, frustration or repeated movement without any clear explanation.

Younger children may notice the tic before they notice the urge. They may not connect the body feeling with the movement or sound. This can make adult reactions very important. Repeated correction can make the child feel blamed for something they cannot explain.

If your child has tics, ask simple, calm questions at a low pressure time.

  • Does anything feel tight before the tic
  • Do your eyes, throat, neck or shoulders feel strange before it happens
  • Does the feeling go away after the tic
  • Does holding it in feel hard
  • Does anything hurt

Do not ask these questions during every tic. Constant checking can make the child feel watched. A short conversation before a care visit can be enough.

Adults and tic awareness

Adults may describe premonitory urges in more detail because they have lived with the pattern longer. You may know which body area signals a tic. You may also know which settings make urges harder to ignore.

Tic awareness can help you plan. If you know throat pressure often comes before a vocal tic, you may take a brief break before a meeting. If you know neck tension comes before a painful movement, you may discuss CBIT, pain care or ergonomics with a clinician.

Awareness can also bring stress if it turns into constant monitoring. The aim is to notice useful patterns without making every body feeling a warning sign. You need enough awareness to talk with your clinician and use trained skills, not a full day spent scanning for symptoms.

If urges are painful, intense or linked with self injury, ask for clinical support. A care plan may include behavioral treatment, medication review, school or work support, pain care or treatment for related anxiety or obsessive symptoms.

Premonitory urges in CBIT

Premonitory urges are important in Comprehensive Behavioral Intervention for Tics, often called CBIT. CBIT is a behavioral therapy for tic disorders. The Centers for Disease Control and Prevention (CDC) describes CBIT as a planned therapy that helps a person become aware of tics and learn new responses to them.

CBIT often includes awareness training. You learn to notice early signs that a tic may happen. That early sign may be a premonitory urge, a body feeling or a pattern in the setting.

CBIT also includes a competing response. This is a safe action that makes the tic harder to perform. A trained provider helps choose the response. For a blinking tic, the response may involve a controlled eye action. For a throat clearing tic, it may involve a breathing action. The response should be safe and matched to your tic.

A large clinical trial published in JAMA described awareness training as self monitoring current tics and focusing on premonitory urges or other early signs that a tic is about to occur.

CBIT does not mean tics are voluntary. It means some people can learn skills that reduce tic impact. A person can have involuntary tics and still learn helpful responses with practice.

Tracking without forcing control

Tracking premonitory urges can help before a care visit or during CBIT. It should stay brief and calm.

You can track the following.

  • Which tic happens
  • Where you feel the urge
  • What the urge feels like
  • How strong it feels
  • How long it lasts
  • What happens after the tic
  • What setting you were in
  • Any pain, stress or fatigue

For children, parents can track quietly. Avoid asking the child to explain every tic. The child may feel pressure or embarrassment. Ask about pain and discomfort first.

For teens, respect privacy. Ask before writing notes or recording symptoms. A teen may already feel exposed in school or public settings.

For adults, focus on patterns that affect life. Track urges that affect work, driving, public speaking, sleep, pain, social settings or relationships. Bring the notes to a qualified healthcare professional.

When the urge feels different from anxiety or compulsion

Premonitory urges can overlap with anxiety and obsessive compulsive symptoms, but they are often described differently. A tic urge is commonly a body sensation that eases after a movement or sound.

A compulsion is often linked with a fear, doubt or mental rule. A person may repeat an action to reduce anxiety or prevent a feared outcome. Some people have both tics and obsessive compulsive symptoms, so the difference can be hard to sort out alone.

A clinician may ask what happens before the action. Is there body pressure, a thought, a fear, a need for things to feel complete or a mix of these? The answer can help guide care.

If obsessive thoughts, anxiety or repeated rituals are taking up time or causing distress, mention them during the visit. Treating tics alone may not address the full symptom pattern.

Safe ways to respond to the urge

Safe responses depend on the tic, the setting and any treatment plan you have. If you are in CBIT, use the response taught by your provider. Do not create forceful or painful responses on your own.

General support steps may include taking a brief break, lowering pressure, moving to a safer setting, using calm breathing or asking for support. These steps may not stop the tic, but they can reduce distress around it.

Avoid unsafe responses. Do not restrain a child. Do not shame the person for ticcing. Do not use pain to stop the tic. Do not force long suppression. If a tic is dangerous, painful or self injurious, seek clinical care.

If you are trying to help a child, keep your tone steady. You can ask, “Does anything hurt?” or “Do you need a break?” You do not need to comment on every tic.

Links to CBIT and managing tics

If you hear the term premonitory urge during treatment planning, read a CBIT guide next. CBIT uses tic awareness and competing responses, and premonitory urges are often part of that skill work.

If you need daily support, read a managing tics guide. That page should cover school, work, public settings, family communication, tic tracking and ways to reduce shame around symptoms.

If you are still sorting out symptoms, read a Tourette syndrome symptoms guide. That page should explain motor tics, vocal tics, simple tics, complex tics and changes over time.

If the main symptoms are repeated movements, read a motor tics guide. If the main symptoms are repeated sounds, read a vocal tics guide.

Research context

Premonitory urges are an active research topic because they may help explain tic awareness, tic suppression, behavioral treatment and the body sensations linked with tic disorders. Better research can help clinicians teach skills in a way that fits children, teens and adults.

Regulated psychedelic research is also helping scientists study brain networks, neuroplasticity and future therapeutic models. Psilocybin is not an established treatment for premonitory urges, Tourette syndrome or tic disorders. Any future research in this area should use clear diagnostic criteria, validated tic measures, careful safety review and attention to ADHD, OCD and anxiety.

Research note

As you review premonitory urges, tic awareness and future research questions, we at Rose Hill Life Sciences approach this topic through science led education. Our work focuses on psychedelic research, production and study of Psilocybe cubensis, the intersection of science and therapeutic integration and our Massachusetts research work, while tic diagnosis and treatment decisions should remain with qualified healthcare professionals.

Conclusion

If you notice a feeling before a tic, write down where you feel it, what it feels like and which tic follows it. Keep notes short. Bring them to your clinician, especially if tics cause pain, school issues, work limits, social stress or distress.

If a child cannot explain the urge, watch for patterns without pressure. Ask about discomfort, pain and school problems. Avoid repeated correction.

If you are in CBIT or considering it, ask how premonitory urges fit into awareness training and competing responses. A trained provider can help you use tic awareness in a safe and practical way.

Disclaimer: The information in this article is for educational and informational purposes only and does not constitute medical advice.

You May Also Like

Adam Goodman

Advisor

Adam is a seasoned entrepreneur with a wealth of experience in spearheading real estate development and management endeavors. His focus primarily lies in land development, where he orchestrates the intricate tapestry of planning and zoning entitlements, while meticulously overseeing all facets of engineering and architectural design, leasing, construction, and financing.

With a national reach spanning 23 states and encompassing over 250 properties, totaling more than 6 million square feet, Adam’s proficiency in navigating the complexities of the industry is evident.

Beyond real estate, Adam’s endeavors extend into the realm of alternative investments, boasting successful ventures in healthcare, professional sports franchises, financial services, diverse agricultural platforms, and the stewardship of local restaurants.

 

Rotem Petranker, PhD, Psychology

Psychedelic Researcher

Rotem Petranker is a psychedelics researcher with a particular emphasis on microdosing, therapy, research methods and research ethics. He earned his BSc from the University of Toronto, his Master’s degree from York University, and his PhD from McMaster University.

As part of my research, I have gained extensive expertise in navigating the regulatory landscapes of Health Canada and the FDA and a strong background in designing rigorous clinical trial research methodologies. 

I founded the Canadian Centre for Psychedelic Science in 2018, established the Psychedelic Science Research Program at the University of Toronto in 2019, and, more recently, ran the largest clinical trial to date on the effectiveness of microdosing psilocybin for Major Depressive Disorders. I have published many papers on microdosing, including some of the largest samples in the literature and some that have set standards for performing psychedelic research.

Kevin Bourke

Chief Commercial Officer

Kevin Bourke is a dynamic executive and strategic planner whose career spans over two decades of crafting and elevating world-class Jamaican brands and transformational experiences on the global stage. With a keen understanding of culture, identity, and international markets, he has played a pivotal role in shaping some of Jamaica’s most iconic names — including Appleton Estate Rum, Chris Blackwell’s Rum, and Usain Bolt’s Tracks & Records — bringing them from local roots to international acclaim. His leadership and vision have also been instrumental in major cultural movements such as Fiction and the internationally recognized TmrwTday Wellness Festival.

An innovator at heart, Mr. Bourke seamlessly blends brand strategy with deep cultural resonance. His ability to connect with diverse audiences has established these brands not only as commercial successes but as symbolic ambassadors of Jamaican excellence, fortifying the island’s influence in beverage, music, lifestyle, and experiential sectors.

In recent years, Kevin has steered his strategic acumen toward the cutting-edge psilocybin and wellness industry, becoming a co-founder and Chief Marketing and Branding Officer of Rose Hill, Jamaica’s leading cultivator, exporter, and innovator of psilocybin products and experiences. Through ventures like ONE Retreats, he has helped craft safe, guided psychedelic-assisted healing programs that attract participants from around the world seeking deep personal transformation, including military veterans and international wellness seekers.

Kevin’s impact extends beyond business into industry shaping and policy, as he sits on the Jamaica Psilocybin Mushroom Industry Technical Committee (under the Bureau of Standards) — a pivotal body that is formalizing guidelines and regulatory standards for the emerging legal psilocybin sector in Jamaica. His presence on this committee underscores his leadership role in ensuring the industry’s integrity, safety, and sustainable growth.

Highly regarded for his extensive network throughout Jamaica and internationally, Kevin remains passionately committed to advancing ethical, high-integrity product development and customer-centric experiences at every level. His dedication is driven not only by professional achievement but by a deep vision for human well-being, cultural celebration, and the global evolution of plant-based healing.

Jama Pitman

Regulatory Strategy

Jama Pitman is a seasoned biopharmaceutical executive with extensive expertise in global drug development and commercialization. With over two decades of experience, she has contributed to the development of groundbreaking therapies across oncology, rare diseases, and antivirals. As a strategic leader, she has successfully transitioned companies from private to public markets, navigated complex M&A transactions, and driven innovative drug approvals.

Jama has held executive roles in leading organizations, including Deciphera Pharmaceuticals, where she played a pivotal role in scaling operations from a small, privately held biotech company to a global, multi-product company acquired for $2.4 billion. She brings exceptional skills in regulatory affairs, portfolio management, quality assurance, and clinical operations, longside a proven track record of fostering inclusivity and mentorship within her teams.

Currently, as the founder of JP BioPharma Consulting, Jama advises biopharma and tech companies on accelerating drug development and achieving corporate goals. Her collaborative and forward-thinking approach aligns seamlessly with Rose Hill’s mission to advance transformative therapies in mental health and beyond.

Education: B.Sc. in Microbiology, University of New Hampshire.

Notable Achievements: Contributed to the development of multiple FDA-approved therapies, including QINLOCK® for gastrointestinal stromal tumors.

Domenic Suppa

Chief Operating Officer

Domenic is co-founder and the Operations Chief of Rose Hill Health Holdings.

He has been working as a Cannabis technology and operations veteran with more than 11 years’ experience as a senior executive in an operationally complex, and highly regulated industry.

His introduction and entrance into the Cannabis sector started in 2010 with a seed investment into a Denver-based vertically integrated cannabis company called, Evolab. He served as C.O.O. for 5 years from 2013-2018, through the eventual acquisition by Harvest Health and Recreation (HARV: CSE).

Domenic moved on to be acting COO of the manufacturing division for Supreme Cannabis (CSE: FIRE) and supported the acquisition of BLISSCO (CSE: BLISS, a BC-based cannabis manufacturer). Domenic has worked with high-profile national cannabis brands including KKE, and Monogram, and retail brands in MA Native Sun, Terps, and Tilt. Domenic is a proven leader and team builder; his previous experiences have all been with early-stage and growth equity enterprises.

He has refined and evolved his leadership roles, including his team-building skills. He is a value creator. Domenic is a firm believer in training and continuous development. He excels in employing practices, tools, and methodologies designed to achieve maximum process efficiency while minimizing waste and delays.

 

Burton J. Tabaac

Clinical Development

Dr. Burton J. Tabaac, MD, FAHA, brings a wealth of expertise in neurology and stroke rehabilitation to Rose Hill. As an Associate Professor and Section Chief of Neurology at The University of Nevada’s Reno School of Medicine, and Medical Director of Stroke at Carson Tahoe Health, Dr. Tabaac has been at the forefront of innovative neurological treatments.

A graduate of the prestigious cerebrovascular neurology fellowship program at The Johns Hopkins University Hospital, Dr. Tabaac’s accolades include being a three-time recipient of The Arnold P. Gold Foundation’s Humanism and Excellence in Teaching Award and induction into the Alpha Omega Alpha Honor Medical Society.

He recently published an eight-part paper in the American Journal of Therapeutics reviewing psychedelics as therapeutics for primary care clinicians. Dr. Tabaac’s groundbreaking research focuses on the application of psychedelics in brain injury and stroke rehabilitation.

Dr. Tabaac was recently appointed by the Governor of Nevada to serve as a member of the state’s Psychedelic Medicines Working Group, which provides expertise and testimony relating to the therapeutic use of entheogens.

As the host of The Zero Hour Podcast, he engages with leading experts in psychedelic research. His commitment to advancing the field was further highlighted in his 2022 TEDx talk at UCLA, “Mental Health Meets Psychedelics.”

“Joining Rose Hill’s advisory team presents an exciting opportunity to further explore the potential of psilocybin in neurological recovery,” said Dr. Tabaac.

“The company’s commitment to ethical cultivation and research aligns perfectly with my vision for advancing patient care through innovative therapies. I’m eager to bring my expertise to Rose Hill and contribute to the evolving landscape of psychedelic medicine.”

Charles Lazarus

Chief Executive Office

Mr. Lazarus boasts over 16 years of extensive expertise in psilocybin and cannabis, focusing on genetic development, cultivation, extraction, and operations logistics. Notably, he recently achieved a milestone by cultivating and delivering the largest legal shipment of premium psilocybin globally.

As an accomplished owner/operator, Mr. Lazarus has successfully managed multiple farming and harvesting businesses, earning commendations for his unwavering commitment to quality and impressive output volumes. Since 2015, he has been actively involved in producing proprietary psilocybin genetics and cultivation solutions tailored for the Jamaican market and large research and development clients.

His contributions span various aspects, including genetic development, cultivation, extraction, harvest, and logistics. Additionally, Mr. Lazarus owned and operated Island Fresh Ltd., a venture that played a pivotal role in exporting fresh fruit, ground provisions, and promoting brand Jamaica to the English market. Under his leadership, Island Fresh Ltd. achieved the highest volume from Jamaica for three consecutive years.

Mr. Lazarus’s extensive experience also includes serving as the Harvest Manager for cannabis grow operations in California from 2013 to 2017, further solidifying his comprehensive knowledge in the cannabis industry.